Skip to content

Clinical observation of the influence of diabetes on the prognosis of herpes zoster

Clinical observation of the influence of diabetes on the prognosis of herpes zoster

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900025070
Enrollment
Unknown
Registered
2019-08-09
Start date
2019-08-09
Completion date
Unknown
Last updated
2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

herpes zoster

Interventions

Diabetes group:Sodium foscarinate injection
Nondiabetes group:Sodium foscarinate injection

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Aged 50 to 90 years; 2. The course of disease within 7 days; 3. VAS >= 4 points; 4. All patients agreed to participate in the experiment and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Allergic to infrared rays, allergic to basic therapeutic drugs; 2. Combine other pains; 3. Combined with other skin diseases, such as eczema, psoriasis, polymorphous erythema, etc.; 4. There are liver and kidney dysfunction, coagulation dysfunction; 5. Patients with other serious organic diseases; 6. Long-term use of glucocorticoids or immunosuppressive agents; 7. History of abuse of opioids.

Design outcomes

Primary

MeasureTime frame
VAS;

Secondary

MeasureTime frame
AIS;HADS;

Countries

China

Contacts

Public ContactZhiping Wei

Affiliated Hospital of Xuzhou Medical University

XZWZP1961@aliyun.com+86 18052268255

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026